Recent developments in multiple system atrophy

Journal of Neurology

Volumn 256, Issue 11, 2009, Pages 1791-1808

  Wenning, Gregor K ^a   Stefanova, Nadia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alpha synuclein; Atypical parkinsonism; Autonomic failure; Multiple system atrophy; Neurodegeneration

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; METABOLISM; REVIEW; SHY DRAGER SYNDROME;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE PROGRESSION; HUMANS; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; SHY-DRAGER SYNDROME;

EID: 73449102917     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5173-8     Document Type: Review

References (217)

1. Abele M, Minnerop M, Urbach H, Specht K, Klockgether T (2007) Sporadic adult onset ataxia of unknown etiology: A clinical, electrophysiological and imaging study. J Neurol 254:1384-1389. doi:10.1007/s00415-007-0556-1 (Pubitemid 350112326)
2. Alam M, Smith G, Bleasdale-Barr K, Pavitt DV, Mathias CJ (1995) Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 13:1664-1669 (Pubitemid 26015794)
3. Albanese A, Colosimo C, Lees AJ, Tonali P (1996) The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism. Adv Neurol 69:393-398
4. Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A (2008) Oculomotor function in multiple system atrophy: Clinical and laboratory features in 30 patients. Mov Disord 23:977-984. doi:10.1002/mds.21999
5. Arima K, Murayama S, Mukoyama M, Inose T (1992) Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions. Acta Neuropathol 83:453-460. doi:10.1007/BF00310020
6. Armstrong RA, Lantos PL, Cairns NJ (2004) Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Mov Disord 19:109-112. doi:10.1002/mds.10637 (Pubitemid 38559631)
7. Armstrong RA, Cairns NJ, Lantos PL (2006) Multiple system atrophy (MSA): Topographic distribution of the alpha-synucleinassociated pathological changes. Parkinsonism Relat Disord 12:356-362. doi:10.1016/j.parkreldis.2006.02.005 (Pubitemid 44189900)
8. Beck RO, Betts CD, Fowler CJ (1994) Genitourinary dysfunction in multiple system atrophy: Clinical features and treatment in 62 cases. J Urol 151:1336-1341 (Pubitemid 24121948)
9. Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423-425. doi:10.1136/jnnp.2004. 049221 (Pubitemid 40299138)
10. Ben Shlomo Y, Wenning GK, Tison F, Quinn NP (1997) Survival of patients with pathologically proven multiple system atrophy: A meta-Analysis. Neurology 48:384-393 (Pubitemid 27087609)
11. Benarroch EE (2003) Brainstem in multiple system atrophy: Clinicopathological correlations. Cell Mol Neurobiol 23:519-526. doi:10.1023/A:1025067912199 (Pubitemid 37071481)
12. Benarroch EE, Schmeichel AM, Low PA, Parisi JE (2004) Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 55:418-422. doi:10.1002/ana.20021 (Pubitemid 38269594)
13. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE (2006) Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 66:378-383. doi:10.1212/01.wnl.0000196638.98781.bb (Pubitemid 43739940)
14. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE (2007) Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 113:75-80. doi:10.1007/s00401-006-0150-0 (Pubitemid 44782931)
15. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS study. Brain 132:156-171. doi:10.1093/brain/awn291
16. Berciano J, Monton FI, Maeso MC, Ferrer I (2002) Man aged 49 years suffering from progressive clinical picture with palatal tremor, segmental myoclonus, ataxia, parkinsonism, amyotrophy, pyramidal signs, supranuclear ophthalmoplegia and cognitive decline. Neurologia 17:237-243 (Pubitemid 35244437)
17. Berciano J, Boesch S, Perez-Ramos JM, Wenning GK (2006) Olivopontocerebellar atrophy: Toward a better nosological definition. Mov Disord 21:1607-1613. doi:10.1002/mds.21052 (Pubitemid 44742186)
18. Blandini F, Armentero MT, Fancellu R, Blaugrund E, Nappi G (2004) Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Exp Neurol 187:455-459. doi:10.1016/j.expneurol.2004.03.005 (Pubitemid 38610291)
19. Boesch SM, Wenning GK, Ransmayr G, Poewe W (2002) Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 72:300-303. doi:10.1136/jnnp.72.3. 300 (Pubitemid 34185195)
20. Bosman T, Van Laere K, Santens P (2003) Anatomically standardised 99 mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 30:16-24. doi:10.1007/s00259-002-1009-9 (Pubitemid 36692888)
21. Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11:351-355. doi:10.1007/BF02292766 (Pubitemid 34461714)
22. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH (1999) Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 53:1020-1025 (Pubitemid 29442118)
23. Brenneis C, Egger K, Scherfler C, Seppi K, Schocke M, Poewe W, Wenning GK (2007) Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 254:191-196. doi:10.1007/s00415-006-0325-6 (Pubitemid 46356051)
24. Brooks DJ, Seppi K for the Neuroimaging Working Group on MSA (2009) Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord (in press
25. Brown RC, Lockwood AH, Sonawane BR (2005) Neurodegenerative diseases: An overview of environmental risk factors. Environ Health Perspect 113:1250-1256 (Pubitemid 41387669)
26. Casarejos MJ, Menendez J, Solano RM, Rodriguez-Navarro JA, Garcia dY, Mena MA (2006) Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 97:934-946. doi:10.1111/j.1471-4159.2006.03777.x
27. Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF (2004) Epidemiology of multiple system atrophy: A prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 23:201-208. doi:10.1159/000078506 (Pubitemid 38980446)
28. Combarros O, Infante J, Llorca J, Berciano J (2003) Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov Disord 18:1385-1386. doi:10.1002/mds. 10540 (Pubitemid 38263331)
29. Daniel S (1999) The neuropathology and neurochemistry of multiple system atrophy. In: Mathias CJ, Bartko JJ (eds) Autonomic failure. Oxford University Press, Oxford, pp 321-328
30. Dickson DW, Lin W, Liu WK, Yen SH (1999) Multiple system atrophy: A sporadic synucleinopathy. Brain Pathol 9:721-732 (Pubitemid 29470964)
31. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, Feigin A, Eidelberg D (2008) Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23:727-733. doi:10.1002/mds.21933
32. Eichhorn TE, Oertel WH (2001) Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 16:1176-1177. doi:10.1002/mds. 1211 (Pubitemid 36041238)
33. El Fakhri G, Habert MO, Maksud P, Kas A, Malek Z, Kijewski MF, Lacomblez L (2006) Quantitative simultaneous (99 m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 33:87-92. doi: 10.1007/s00259-005-1920-y (Pubitemid 41785314)
34. Eliash S, Speiser Z, Cohen S (2001) Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats. J Neural Transm 108:909-923. doi:10.1007/s007020170012 (Pubitemid 32802090)
35. Eliash S, Shteter N, Eilam R (2005) Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model. J Neural Transm 112:991-1003. doi:10.1007/s00702-004-0254-4 (Pubitemid 40991515)
36. Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, Mentis MJ, Moeller JR, Eidelberg D (2002) Tc-99 m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265-1270. doi:10.1002/mds. 10270 (Pubitemid 36041340)
37. Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, Bioulac B, Tison F (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57B1/6 mice: Behavioural and histopathological characterisation. Neuroscience 114:1005-1017
38. Finberg JP, Takeshima T, Johnston JM, Commissiong JW (1998) Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. Neuroreport 9:703-707 (Pubitemid 28131289)
39. Friess E, Kuempfel T, Modell S, Winkelmann J, Holsboer F, Ising M, Trenkwalder C (2006) Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism Relat Disord 12:432-437. doi:10.1016/j. parkreldis.2006.04.002 (Pubitemid 44416291)
40. Furiya Y, Hirano M, Kurumatani N, Nakamuro T, Matsumura R, Futamura N, Ueno S (2005) Alpha-1-Antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res Mol Brain Res 138:178-181. doi:10.1016/j. molbrainres.2005.04.011 (Pubitemid 41138036)
41. Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study. Lancet Neurol 7:417-424. doi: 10.1016/S1474-4422(08)70067-X
42. Galanaud JP, Elbaz A, Clavel J, Vidal JS, Correze JR, Alperovitch A, Tzourio C (2005) Cigarette smoking and Parkinson's disease: A case-control study in a population characterized by a high prevalence of pesticide exposure. Mov Disord 20:181-189. doi:10.1002/mds.20307 (Pubitemid 40361121)
43. Geser F, Seppi K, Stampfer-Kountchev M, Kollensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK (2005) The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm 112:1677-1686. doi: 10.1007/s00702-005-0328-y (Pubitemid 41598973)
44. Ghorayeb I, Bioulac B, Tison F (2005) Sleep disorders in multiple system atrophy. J Neural Transm 112:1669-1675. doi: 10.1007/s00702-005-0348-7 (Pubitemid 41598972)
45. Gilman S, Sima AA, Junck L, Kluin KJ, Koeppe RA, Lohman ME, Little R (1996) Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 39:241-255. doi:10.1002/ana.410390214 (Pubitemid 26071575)
46. Gilman S, Low P, Quinn N, Albanese A, Ben Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8:359-362. doi:10.1007/BF02 309628 (Pubitemid 29021108)
47. Gilman S, Low PA, Quinn N, Albanese A, Ben Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94-98. doi:10.1016/S0022-510X(98)00304-9 (Pubitemid 29155424)
48. Gilman S, Koeppe RA, Chervin RD, Consens FB, Little R, An H, Junck L, Heumann M (2003) REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 61:29-34 (Pubitemid 36818742)
49. Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, Masliah E, Low P, Sandroni P, Trojanowski JQ, Ozelius L, Foroud T (2005) The North American Multiple System Atrophy Study Group. J Neural Transm 112:1687-1694. doi: 10.1007/s00702-005-0381-6 (Pubitemid 41598974)
50. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670-676. doi:10.1212/01.wnl. 0000324625.00404.15
51. Graham JG, Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32:28-34. doi:10.1136/jnnp. 32.1.28
52. Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Bruhl B, Hofner K, Jonas U (2003) Controlled, double-blind, multicentre clinical trial to investigate long-Term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 20:392-399 (Pubitemid 44175311)
53. Hanna PA, Jankovic J, Kirkpatrick JB (1999) Multiple system atrophy: The putative causative role of environmental toxins. Arch Neurol 56:90-94. doi:10.1001/archneur.56.1.90 (Pubitemid 29046914)
54. Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, Kakita A, Yamada M, Takahashi H, Hirasawa M, Mizuno Y, Ogata K, Goto J, Kanazawa I, Nishizawa M, Tsuji S (2007) Multiplex families with multiple system atrophy. Arch Neurol 64:545-551. doi:10.1001/archneur.64.4.545 (Pubitemid 46588344)
55. Hauser TK, Luft A, Skalej M, Nagele T, Kircher TT, Leube DT, Schulz JB (2006) Visualization and quantification of disease progression in multiple system atrophy. Mov Disord 21:1674-1681. doi:10.1002/mds.21032 (Pubitemid 44742197)
56. Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T (2007) Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study. Mov Disord 22:1138-1144. doi:10.1002/mds.21501 (Pubitemid 47067224)
57. Huang W, Chen Y, Shohami E, Weinstock M (1999) Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. Eur J Pharmacol 366:127-135. doi:10.1016/S0014-2999(98) 00929-7 (Pubitemid 29080775)
58. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499 (Pubitemid 32995738)
59. Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ (2001) Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 71:371-374. doi:10.1136/jnnp. 71.3.371 (Pubitemid 32772536)
60. Infante J, Llorca J, Berciano J, Combarros O (2005) Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factoralpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 228:11-13. doi:10.1016/j.jns.2004.09.023 (Pubitemid 39656488)
61. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: A correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93:585-591. doi:10.1007/s004010050655 (Pubitemid 27239247)
62. Iranzo A, Santamaria J, Tolosa E, Vilaseca I, Valldeoriola F, Marti MJ, Munoz E (2004) Long-Term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 63:930-932 (Pubitemid 39297666)
63. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T (2004) Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 63:43-52 (Pubitemid 38030232)
64. Ito M, Watanabe H, Kawai Y, Atsuta N, Tanaka F, Naganawa S, Fukatsu H, Sobue G (2007) Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 78:722-728. doi:10.1136/jnnp.2006.104075 (Pubitemid 46998843)
65. Jain S, Dawson J, Quinn NP, Playford ED (2004) Occupational therapy in multiple system atrophy: A pilot randomized controlled trial. Mov Disord 19:1360-1364. doi:10.1002/mds.20211 (Pubitemid 39534558)
66. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM (1993) Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine. Am J Med 95:38-48. doi:10.1016/0002- 9343(93)90230-M (Pubitemid 23205925)
67. Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18(Suppl 6):S2-S12. doi:10.1002/mds. 10557 (Pubitemid 37185190)
68. Jellinger KA (2006) P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol 112:112. doi:10.1007/s00401-006-0075-7 (Pubitemid 43942168)
69. Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: Proposal for a novel scale. Mov Disord 20(Suppl 12):S29-S36. doi:10.1002/mds.20537 (Pubitemid 41419552)
70. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D (1998) Contrasting actions of pressor agents in severe autonomic failure. Am J Med 105:116-124. doi:10.1016/S0002-9343(98)00193-4 (Pubitemid 28405234)
71. Juh R, Pae CU, Lee CU, Yang D, Chung Y, Suh T, Choe B (2005) Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neurosci Res 52:211-219. doi: 10.1016/j.neures.2005.03.010 (Pubitemid 40775759)
72. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W, Fuss B, Mallon B, Macklin WB, Fujiwara H, Hasegawa M, Iwatsubo T, Kretzschmar HA, Haass C (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3:583-588. doi: 10.1093/embo-reports/kvf109 (Pubitemid 34752460)
73. Kamm C, Healy DG, Quinn NP, Wullner U, Moller JC, Schols L, Geser F, Burk K, Borglum AD, Pellecchia MT, Tolosa E, del Sorbo F, Nilsson C, Bandmann O, Sharma M, Mayer P, Gasteiger M, Haworth A, Ozawa T, Lees AJ, Short J, Giunti P, Holinski-Feder E, Illig T, Wichmann HE, Wenning GK, Wood NW, Gasser T (2005) The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: Data from the EMSA Study Group. Brain 128:1855-1860. doi:10.1093/brain/awh535 (Pubitemid 41373657)
74. Kanazawa M, Shimohata T, Terajima K, Onodera O, Tanaka K, Tsuji S, Okamoto K, Nishizawa M (2004) Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol 251:1121-1124. doi: 10.1007/s00415-004-0494-0 (Pubitemid 39297209)
75. Kato S, Nakamura H (1990) Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies. Acta Neuropathol 79:584-594. doi:10.1007/BF00 294235 (Pubitemid 20170334)
76. Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724-728. doi:10.1161/01.CIR.0000083721. 49847.D7 (Pubitemid 36999258)
77. Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, Ito K, Sobue G (2008) Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 70:1390-1396. doi:10.1212/01.wnl.0000 310413.04462.6a (Pubitemid 351521930)
78. Khan NL, Giunti P, Sweeney MG, Scherfler C, Brien MO, Piccini P, Wood NW, Lees AJ (2005) Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Mov Disord 20:1115-1119. doi:10.1002/mds.20564 (Pubitemid 41632197)
79. Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE (2002) Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 17:303-312. doi:10.1002/mds.10042 (Pubitemid 36041299)
80. Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ (2003) Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: A retrospective study. Int J Impot Res 15:293-298. doi:10.1038/sj.ijir.3901014 (Pubitemid 37101666)
81. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE (2005) Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 11:381-386. doi:10.1016/j.parkreldis.2005.06.005 (Pubitemid 41317806)
82. Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, Videbaek C, Werdelin L (2004) Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 31:1631-1638. doi:10.1007/s00259-004-1578-x (Pubitemid 40104609)
83. Kollensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Low PA, Mathias CJ, Poewe W, WenningGK(2007) Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment. Eur J Neurol 14:66-72. doi:10.1111/j.1468-1331.2006.01554.x (Pubitemid 46088039)
84. Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord 23:1093-1099. doi:10.1002/mds.21992
85. Kollensperger M, Stefanova N, Pallua A, Puschban Z, Dechant G, Hainzer M, Reindl M, Poewe W, Nikkhah G, Wenning GK (2009) Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response. J Neurosci Res 87:1679-1685
86. Konno H, Yamamoto T, Iwasaki Y, Iizuka H (1986) Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 73:193-204. doi:10.1016/0022-510X(86) 90130-9 (Pubitemid 16125281)
87. Kovacs GG, Gelpi E, Lehotzky A, Hoftberger R, Erdei A, Budka H, Ovadi J (2007) The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol 113:153-161. doi:10.1007/s00401- 006-0167-4 (Pubitemid 46158148)
88. Kume A, Takahashi A, Hashizume Y (1993) Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 117:33-40. doi:10.1016/0022-510X(93)90151-N (Pubitemid 23274646)
89. Kwon KY, Choi CG, Kim JS, Lee MC, Chung SJ (2007) Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Mov Disord 22:2352-2358. doi:10.1002/mds.21714 (Pubitemid 351155980)
90. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2006) Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study. Mov Disord 21:704-707. doi:10.1002/mds.20793 (Pubitemid 43792756)
91. Lang AE, Lozano A, Duff J, Tasker R, Miyasaki J, Galvez-Jimenez N, Hutchison W, Dostrovsky J (1997) Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. Adv Neurol 74:199-211
92. Lantos PL (1998) The definition of multiple system atrophy: A review of recent developments. J Neuropathol Exp Neurol 57:1099-1111. doi:10.1097/ 00005072-199812000-00001 (Pubitemid 28562738)
93. Lee WY, Jin DK, Oh MR, Lee JE, Song SM, Lee EA, Kim GM, Chung JS, Lee KH (2003) Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 60:858-863. doi:10.1001/archneur.60.6.858 (Pubitemid 36705974)
94. Lee PH, An YS, Yong SW, Yoon SN (2008) Cortical metabolic changes in the cerebellar variant of multiple system atrophy: A voxel-based FDG-PET study in 41 patients. Neuroimage 40:796-801. doi:10.1016/j.neuroimage.2007.11.055
95. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K (2008) Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 83:723-730. doi:10.1038/sj. clpt.6100386 (Pubitemid 351556019)
96. Lezcano E, Gomez-Esteban JC, Zarranz JJ, Alcaraz R, Atares B, Bilbao G, Garibi J, Lambarri I (2004) Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: A clinicopathological case report. Mov Disord 19:973-977. doi:10.1002/mds.20108 (Pubitemid 39199271)
97. Lincoln SJ, Ross OA, Milkovic NM, Dickson DW, Rajput A, Robinson CA, Papapetropoulos S, Mash DC, Farrer MJ (2007) Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat Disord 13:340-342. doi:10.1016/j.parkreldis.2006.12.005 (Pubitemid 47212789)
98. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH (2005) p25alpha Stimulates alpha-synuclein aggregation and is colocalized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 280:5703-5715. doi:10.1074/jbc. M410409200 (Pubitemid 40280050)
99. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 277:1046-1051. doi: 10.1001/jama.277.13.1046 (Pubitemid 27147542)
100. Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, Lee JH, Rinne JO, Lee MS (2008) Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain 131:438-446. doi:10.1093/brain/awm328 (Pubitemid 351197623)
101. Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C (2003) Double-blind, placebocontrolled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18:685-688. doi:10.1002/mds.10420 (Pubitemid 36790285)
102. Mandel SA, Sagi Y, Amit T (2007) Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway. Neurochem Res 32:1694-1699. doi: 10.1007/s11064-007-9351-8 (Pubitemid 47428857)
103. Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R (1986) The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 293:353-354. doi:10.1136/bmj.293.6543.353 (Pubitemid 16043927)
104. Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD (2001) L-Threo-dihydroxyphenylserine (L-Threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, doseranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11:235-242. doi:10.1007/BF02298955 (Pubitemid 33043693)
105. Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M (2005) Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 11:227-232. doi:10.1016/j.parkreldis.2005.01.001 (Pubitemid 40692834)
106. Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 153:735-744 (Pubitemid 28419028)
107. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW (2007) Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 22:2371-2377. doi:10.1002/mds.21734 (Pubitemid 351155983)
108. Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB (2005) Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 112:1613-1624. doi:10.1007/s00702-005-0378-1 (Pubitemid 41598967)
109. Morris HR, Vaughan JR, Datta SR, Bandopadhyay R, Rohan De Silva HA, Schrag A, Cairns NJ, Burn D, Nath U, Lantos PL, Daniel S, Lees AJ, Quinn NP, Wood NW (2000) Multiple system atrophy/progressive supranuclear palsy: Alpha-Synuclein, synphilin, tau, and APOE. Neurology 55:1918-1920 (Pubitemid 32103980)
110. Muller J, Wenning GK, Wissel J, Seppi K, Poewe W (2002) Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 249:300-304. doi:10.1007/s00415-002-0773-6 (Pubitemid 35025119)
111. Munschauer FE, Loh L, Bannister R, Newsom-Davis J (1990) Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology 40:677-679 (Pubitemid 20139100)
112. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 76:249-251. doi:10.1136/jnnp.2004.037028 (Pubitemid 40143717)
113. Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ (1991) Environmental-occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation. Clin Auton Res 1:9-13. doi:10.1007/BF01826052
114. Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A (2006) Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 129:2679-2687. doi: 10.1093/brain/awl166 (Pubitemid 44522101)
115. Nirenberg MJ, Libien J, Vonsattel JP, Fahn S (2007) Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation. Mov Disord 22:251-254. doi:10.1002/mds.21231 (Pubitemid 46374772)
116. Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K (2004) A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 30:546-554. doi:10.1111/j.1365-2990.2004.00564.x (Pubitemid 39423042)
117. Nishimura M, Kawakami H, Komure O, Maruyama H, Morino H, Izumi Y, Nakamura S, Kaji R, Kuno S (2002) Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord 17:808-811. doi:10.1002/mds.10124 (Pubitemid 41295030)
118. Nishimura M, Kuno S, Kaji R, Kawakami H (2005) Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett 374:218-221. doi: 10.1016/j.neulet.2004.10.056 (Pubitemid 40128299)
119. Nonaka M, Imai T, Shintani T, Kawamata M, Chiba S, Matsumoto H (2006) Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci 247:53-58. doi:10.1016/j.jns.2006.03.008 (Pubitemid 44107378)
120. O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362-1372. doi:10.1093/brain/awn065
121. Okawa M, Miwa H, Kajimoto Y, Hama K, Morita S, Nakanishi I, Kondo T (2007) Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: Clinical potential and limitations. Intern Med 46:1527-1531. doi:10.2169/internalmedicine.46.0271 (Pubitemid 47521048)
122. Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007) Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 113:81-86. doi:10.1007/s00401-006-0160-y (Pubitemid 44782932)
123. Ozawa T (2006) Pathology and genetics of multiple system atrophy: An approach to determining genetic susceptibility spectrum. Acta Neuropathol 112:531-538. doi:10.1007/s00401-006-0109-1 (Pubitemid 44550677)
124. Ozawa T (2007) Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: Impact on determining phenotype spectrum. Acta Neuropathol 114:201-211. doi:10.1007/s00401-007-0254-1
125. Ozawa T, Takano H, Onodera O, Kobayashi H, Ikeuchi T, Koide R, Okuizumi K, Shimohata T, Wakabayashi K, Takahashi H, Tsuji S (1999) No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 270:110-112. doi: 10.1016/S0304-3940(99)00475-9 (Pubitemid 29333848)
126. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations. Brain 127:2657-2671. doi: 10.1093/brain/awh303 (Pubitemid 39627375)
127. Papp MI, Lantos PL (1992) Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107:172-182. doi: 10.1016/0022-510X(92)90286-T
128. Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117(Pt 2):235-243. doi:10.1093 /brain/117.2.235 (Pubitemid 24155496)
129. Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79-100. doi:10.1016/0022-510X(89)90219-0 (Pubitemid 20019446)
130. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Longitudinal MRI in progressive supranuclearpalsy and multiple system atrophy: Rates and regions of atrophy. Brain
131. Paviour DC, Price SL, Lees AJ, Fox NC (2007) MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. J Neurol 254:478-481. doi:10.1007/s00415-006-0396-4 (Pubitemid 46786723)
132. Perera R, Isola L, Kaufmann H (1995) Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 5:211-213. doi:10.1007/BF01824009
133. Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brucke T (2000) [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 15:1158-1167. doi:10.1002/1531-8257(200011)15:6\1158::AID-MDS1015[3.0.CO;2-0
134. Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P, Lugaresi E, Cortelli P (1997) REM sleep behavior disorders in multiple system atrophy. Neurology 48:1094-1097
135. Plotkin M, Amthauer H, Klaffke S, Kuhn A, Ludemann L, Arnold G, Wernecke KD, Kupsch A, Felix R, Venz S (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients. J Neural Transm 112:677-692. doi:10.1007/s00702-004-0208-x (Pubitemid 40591200)
136. Probst-Cousin S, Rickert CH, Schmid KW, Gullotta F (1998) Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 57:814-821. doi:10.1097/00005072-199 809000-00002 (Pubitemid 28409396)
137. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214-221. doi:10.1148/radiol.2453061703 (Pubitemid 350305046)
138. Quinn N (1989) Multiple system atrophy-The nature of the beast. J Neurol Neurosurg Psychiatry Suppl:78-89. doi:10.1136/jnnp.52.Suppl.78 (Pubitemid 19167883)
139. Raffel DM, Koeppe RA, Little R, Wang CN, Liu S, Junck L, Heumann M, Gilman S (2006) PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med 47:1769-1777 (Pubitemid 47544999)
140. Raimbach SJ, Cortelli P, Kooner JS, Bannister R, Bloom SR, Mathias CJ (1989) Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: Haemodynamic and hormonal changes. Clin Sci (Lond) 77:623-628 (Pubitemid 20021688)
141. Sakakibara R, Hattori T, Uchiyama T, Suenaga T, Takahashi H, Yamanishi T, Egoshi K, Sekita N (2000) Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 79:191-195. doi:10.1016/S0165-1838(99)00105-8 (Pubitemid 30107867)
142. Sakurai A, Okamoto K, Yaguchi M, Fujita Y, Mizuno Y, Nakazato Y, Gonatas NK (2002) Pathology of the inferior olivary nucleus in patients with multiple system atrophy. Acta Neuropathol 103:550-554. doi:10.1007/s00401-001-0500-x (Pubitemid 36067502)
143. Scherfler C, Puschban Z, Ghorayeb I, Goebel GP, Tison F, Jellinger K, Poewe W, Wenning GK (2000) Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 99:43-54. doi:10.1016/S0306-4522(00)00171-8 (Pubitemid 30495551)
144. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W (2005) Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 128:1605-1612. doi:10.1093/brain/awh485 (Pubitemid 41373679)
145. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE (2008) Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 70:368-373. doi:10.1212/01.wnl. 00 00298691.71637.96 (Pubitemid 351653399)
146. Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Reichmann H, Berg D, Ziemssen T (2008) Autonomic dysfunction in different subtypes of multiple system atrophy. Mov Disord 23:1766-1772. doi:10.1002/mds.22187
147. Schocke MF, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, Wenning GK (2002) Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58:575-580 (Pubitemid 34164939)
148. Scholz SW, Houlden H, Sculte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wüllner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T (2009) SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol (in press
149. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP (2000) Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54:697-702 (Pubitemid 30082941)
150. Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Kollensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK (2006) Health-related quality of life in multiple system atrophy. Mov Disord 21:809-815. doi:10.1002/mds.20808 (Pubitemid 44028301)
151. Schrag A, Wenning GK, Quinn N, Ben Shlomo Y (2008) Survival in multiple system atrophy. Mov Disord 23:294-296. doi: 10.1002/mds.21839 (Pubitemid 351311566)
152. Schulz JB, Klockgether T, Petersen D, Jauch M, Muller-Schauenburg W, Spieker S, Voigt K, Dichgans J (1994) Multiple system atrophy: Natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 57:1047-1056. doi:10.1136/jnnp.57.9.1047
153. Schwarz J, Weis S, Kraft E, Tatsch K, Bandmann O, Mehraein P, Vogl T, Oertel WH (1996) Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 60:98-101. doi:10.1136/jnnp.60.1.98 (Pubitemid 26012276)
154. Schwarz SC, Seufferlein T, Liptay S, Schmid RM, Kasischke K, Foster OJ, Daniel S, Schwarz J (1998) Microglial activation in multiple system atrophy: A potential role for NF-kappaB/rel proteins. Neuroreport 9:3029-3032. doi:10.1097/00001756-199809140-00020 (Pubitemid 28555640)
155. Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, Boesch S, Jaschke W, Poewe W, Wenning GK (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60:922-927. doi:10.1001/archneur. 60.7.922 (Pubitemid 36348922)
156. Seppi K, Schocke MF, Wenning GK, Poewe W (2005) How to diagnose MSA early: The role of magnetic resonance imaging. J Neural Transm 112:1625-1634. doi:10.1007/s00702-005-0332-2 (Pubitemid 41598968)
157. Seppi K, Yekhlef F, Diem A, Luginger WE, Mueller J, Tison F, Quinn NP, Poewe W, Wenning GK (2005) Progression of parkinsonism in multiple system atrophy. J Neurol 252:91-96. doi: 10.1007/s00415-005-0617-2 (Pubitemid 40179024)
158. Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F, Kremser C, Boesch S, Jaschke W, Poewe W, Wenning GK (2006) Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study. Neuroimage 31:240-245. doi:10.1016/j.neuroimage.2005.12.006 (Pubitemid 43728996)
159. Seppi K, Schocke MF, Prennschuetz-Schuetzenau K, Mair KJ, Esterhammer R, Kremser C, Muigg A, Scherfler C, Jaschke W, Wenning GK, Poewe W (2006) Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study. Mov Disord 21:847-852. doi:10.1002/mds.20843 (Pubitemid 44028306)
160. Shimohata T, Ozawa T, Nakayama H, Tomita M, Shinoda H, Nishizawa M (2008) Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 255:1483-1485. doi:10.1007/s00415-008-0941-4
161. Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alphasynuclein under oligodendrocyte promoter: Implications for multiple system atrophy. J Neurosci 25:10689-10699. doi: 10.1523/JNEUROSCI.3527-05.2005 (Pubitemid 41681917)
162. Shy GM, Drager GA (1960) A neurological syndrome associated with orthostatic hypotension: A clinical-pathologic study. Arch Neurol 2:511-527
163. Sitburana O, Ondo WG (2009) Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord 15:165-174
164. Solano SM, Miller DW, Augood SJ, Young AB, Penney JB Jr (2000) Expression of alpha-synuclein, parkin, and ubiquitin carboxy-Terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease. Ann Neurol 47:201-210. doi:10.1002/1531-8249(200002)47:2\201::AIDANA10[ 3.0.CO;2-F (Pubitemid 30078567)
165. Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) Heredity in multiple system atrophy. J Neurol Sci 240:107-110. doi:10.1016/j.jns.2005. 09.003 (Pubitemid 41814963)
166. Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H (2008) Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Mov Disord 23:1161-1167. doi:10.1002/mds.22046
167. Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G (2005) alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 110:19-26. doi:10.1007/s00401-005-1013-9 (Pubitemid 41131193)
168. Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, Jensen PH (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 171:1291-1303. doi:10.2353/ajpath.2007.070201 (Pubitemid 47582902)
169. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208. doi:10.1016/S0304-3940(98)00504-7 (Pubitemid 28381082)
170. Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, Jellinger KA, Poewe W, Wenning GK (2003) Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: Towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol 106:157-166. doi:10.1007/s00401-003-0717-y (Pubitemid 36869251)
171. Stefanova N, Lundblad M, Tison F, Poewe W, Cenci MA, Wenning GK (2004) Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). Neurobiol Dis 15:630-639. doi:10.1016/j.nbd.2003.11.025 (Pubitemid 38429978)
172. Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166:869-876 (Pubitemid 40315643)
173. Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK (2005) Animal models of multiple system atrophy. Trends Neurosci 28:501-506. doi:10.1016/j.tins.2005. 07.002 (Pubitemid 41187800)
174. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Mov Disord 22:2196-2203. doi:10.1002/mds.21671
175. Stefanova N, Poewe W, Wenning GK (2008) Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol 210:421-427. doi:10.1016/j.expneurol.2007. 11.022
176. Stefanova N, Hainzer M, Stemberger S, Couillard-Després S, Aigner L, Poewe W, Wenning GK (2009) Striatal transplantation for multiple system atrophy-Are grafts affected by alphasynucleinopathy? Exp Neurol (in press
177. Tada M, Onodera O, Tada M, Ozawa T, Piao YS, Kakita A, Takahashi H, Nishizawa M (2007) Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 64:256-260. doi:10.1001/archneur.64.2.256
178. Takeda A, Arai N, Komori T, Iseki E, Kato S, Oda M (1997) Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 234:63-66. doi:10.1016/S0304-3940(97)00676-9 (Pubitemid 27435970)
179. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46:1470
180. Thobois S, Broussolle E, Toureille L, Vial C (2001) Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov Disord 16:764-765. doi: 10.1002/mds.1101 (Pubitemid 36040864)
181. Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615-620. doi:10.1111/j. 1365-2990.2007.00907.x (Pubitemid 350076093)
182. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415-422. doi:10.1002/ana.410440324 (Pubitemid 28421453)
183. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R (2004) Statistical parametric mapping of (99 m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: Correlation with clinical parameters. J Nucl Med 45:933-942 (Pubitemid 47611679)
184. Van Laere K, Casteels C, De Ceuninck L, Vanbilloen B, Maes A, Mortelmans L, Vandenberghe W, Verbruggen A, Dom R (2006) Dual-Tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. J Nucl Med 47:384-392 (Pubitemid 46768479)
185. van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG (1993) Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 50:513-516 (Pubitemid 23143144)
186. Vanacore N (2005) Epidemiological evidence on multiple system atrophy. J Neural Transm 112:1605-1612. doi:10.1007/s00702-005-0380-7 (Pubitemid 41598966)
187. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, Bonuccelli U, Stocchi F, Lamberti P, Volpe G, De Michele G, Iavarone I, Bennett P, Vieregge P, Meco G (2000) Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 54:114-119 (Pubitemid 30038747)
188. Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP (2001) [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 16:1023-1032. doi: 10.1002/mds.1256 (Pubitemid 36041214)
189. Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A (2008) Risk factors of multiple system atrophy: A case-control study in French patients. Mov Disord 23:797-803. doi:10.1002/mds.21857
190. Visser-Vandewalle V, Temel Y, Colle H, van der Linden LC (2003) Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases. J Neurosurg 98:882-887 (Pubitemid 36396792)
191. Waibel S, Reuter A, Malessa S, Blaugrund E, Ludolph AC (2004) Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 251:1080-1084. doi:10.1007/s00415-004-0481-5 (Pubitemid 39297202)
192. Wakabayashi K, Takahashi H (2006) Cellular pathology in multiple system atrophy. Neuropathology 26:338-345. doi: 10.1111/j.1440-1789.2006.00713.x (Pubitemid 44086838)
193. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182. doi:10.1016/S0304-3940(98)00407-8 (Pubitemid 28331545)
194. Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, Kuroda N (2005) An autopsy case of early (''minimal change'') olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 110:185-190. doi: 10.1007/s00401-005-1029-1 (Pubitemid 41245208)
195. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60:74-77 (Pubitemid 36070647)
196. Walter U, Dressler D, Probst T, Wolters A, Abu-Mugheisib M, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 64:1635-1640. doi:10.1001/archneur.64.11.1635 (Pubitemid 350106766)
197. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G (2002) Progression and prognosis in multiple system atrophy: An analysis of 230 Japanese patients. Brain 125:1070-1083. doi: 10.1093/brain/awf117 (Pubitemid 34464618)
198. Wenning GK (2005) Placebo-controlled trial of amantadine in multiple-system atrophy. Clin Neuropharmacol 28:225-227. doi:10.1097/01.wnf. 0000183240.47960.f0 (Pubitemid 41579620)
199. Wenning GK, Wagner S, Daniel S, Quinn NP (1993) Multiple system atrophy: Sporadic or familial? Lancet 342:681. doi: 10.1016/0140-6736(93)91789-O (Pubitemid 23271518)
200. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994) Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117(Pt 4):835-845. doi:10.1093/brain/117.4.835 (Pubitemid 24281844)
201. Wenning GK, Granata R, Laboyrie PM, Quinn NP, Jenner P, Marsden CD (1996) Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Disord 11:522-532. doi:10.1002/mds.870110507 (Pubitemid 26306078)
202. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord 12:133-147. doi:10.1002/mds. 870120203 (Pubitemid 27152018)
203. Wenning GK, Ben Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 68:434-440. doi: 10.1136/jnnp.68.4.434 (Pubitemid 30248742)
204. Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93-103. doi:10.1016/S1474-4422(03)00662-8 (Pubitemid 38121312)
205. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: A primary oligodendrogliopathy. Ann Neurol 64:239-246. doi:10.1002/ana.21465
206. Williams DR, Lees AJ (2009) How do patients with parkinsonism present? A clinicopathological study. Intern Med J 39:7-12
207. Winkler AS, Marsden J, Parton M, Watkins PJ, Chaudhuri KR (2001) Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord 16:233-239. doi:10.1002/mds.1063 (Pubitemid 36049970)
208. Wullner U, Abele M, Schmitz-Huebsch T, Wilhelm K, Benecke R, Deuschl G, Klockgether T (2004) Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 75:924-925. doi:10.1136/jnnp.2003.025155 (Pubitemid 38658525)
209. Yamamoto T, Sakakibara R, Uchiyama T, Liu Z, Ito T, Awa Y, Yamamoto K, Kinou M, Yamanishi T, Hattori T (2005) When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry 76:1645-1648. doi:10.1136/jnnp.2004.061036 (Pubitemid 41697627)
210. Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45:847-859. doi:10.1016/j.neuron.2005.01.032 (Pubitemid 40395264)
211. Yokoyama T, Kusunoki JI, Hasegawa K, Sakai H, Yagishita S (2001) Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: Correlation of the density of NCI and the degree of involvement of the pontine nuclei. Neuropathology 21:145-154. doi:10.1046/j.1440-1789.2001.00390.x (Pubitemid 32947276)
212. Yoshida M (2007) Multiple system atrophy: Alpha-synuclein and neuronal degeneration. Neuropathology 27:484-493. doi: 10.1111/j.1440-1789.2007.00841.x (Pubitemid 47459721)
213. Youdim MB, Weinstock M (2001) Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326. Cell Mol Neurobiol 21:555-573. doi:10.1023/A:1015131516649 (N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate (Pubitemid 34538855)
214. Youdim MB, Amit T, Falach-Yogev M, Am OB, Maruyama W, Naoi M (2003) The essentiality of Bcl-2, PKC and proteasomeubiquitin complex activations in the neuroprotective-Antiapoptotic action of the anti-Parkinson drug, rasagiline. Biochem Pharmacol 66:1635-1641. doi:10.1016/S0006-2952(03)00535-5 (Pubitemid 38373356)
215. Young TM, Mathias CJ (2004) The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: Multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry 75:1737-1741. doi:10.1136/jnnp.2004.038471 (Pubitemid 39611476)
216. Zesiewicz TA, Helal M, Hauser RA (2000) Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 15:305-308. doi:10.1002/1531-8257(200003)15:2\305::AID-MDS1015[3.0.CO;2-W (Pubitemid 30166738)
217. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78. doi: 10.1038/417074a (Pubitemid 34498818)